Addiction

New Psychoactive Substances (NPS) Webinar Series

Video and audio recordings
Various NPS have significantly changed the picture of drug use in different countries. They are now very prominent in the drug market. Indeed, many of these substances are intended to circumvent drug laws and are sold as ‘legal’...

The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis

Scientific article
 - 
Comorbid mental illnesses and substance use disorders are associated with adverse criminal, social, and health outcomes. Yet, their burden is not reliably known among prison populations. We therefore aimed to estimate the prevalence of comorbid serious mental illnesses and substance use disorders (dual disorders) among people in prison worldwide.

Project NEPTUNE training modules

Website
In partnership with the Royal College of Psychiatrists, Project NEPTUNE has developed training modules to improve clinical practice in the management of harms resulting from the use of club drugs and novel psychoactive substances. These...

Risks, harms and clinical implications of Novel Psychoactive Substances

Event Date
 - 
Online

As part for the new webinar series of International Society for the Study of Emerging Drugs (ISSED), we are pleased to invite you to attend a workshop on “Health Risks, Harms and Clinical Implications of Novel Psychoactive Substances” facilitated by Prof. Giuseppe Bersani and Prof. Owen Bowden-Jones.

Emerging Trends in Drugs, Addictions, and Health

Scientific article
Emerging Trends in Drugs, Addictions, and Health is a new international journal devoted to the rapid publication of authoritative papers on Novel Psychoactive Substances (NPS), Addiction and associated health phenomena. The Journal has a...

UNODC Early Warning Advisory on New Psychoactive Substances

Website
The rapid emergence of a large number of New Psychoactive Substances on the global drug market poses a significant risk to public health and a challenge to drug policy. Often, little is known about the adverse health effects and social...